MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

June 12, 2015

New Delhi/GenevaThe international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched a global campaign urging Indian Prime Minister Narendra Modi to stand strong in the face of intensifying multinational pressure to change India’s laws and policies that would severely restrict production of affordable medicines, upon which millions of people around the world depend.

April 07, 2015

MSF published evidence from its community-based management of acute malnutrition program in Bihar, India, which revealed that it has successfully achieved a cure rate of 88.4 percent among severely acute malnourished children who completed treatment.

January 26, 2015

Secret meeting this week in New York a chance to remove provisions that threaten access to lifesaving medicines.

January 23, 2015

New intellectual property "think tank" draft policy already showing alarming trend.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

May 15, 2014

 

Although tuberculosis (TB) is preventable and curable, it is the second-biggest infectious disease killer behind HIV and claims nearly 1.3 million lives each year.

The spread of drug-resistant strains of the disease is increasingly recognized as a public health emergency. Drug-resistant tuberculosis (DR-TB) is an umbrella term that refers to tuberculosis strains which resist the drugs routinely used to treat conventional TB.

October 30, 2013

In the mountainous region of Nagaland, northeast India, Doctors Without Borders/Médecins Sans Frontières (MSF) is working with local groups and health authorities to treat people with drug-resistant tuberculosis (DR-TB), a form of the disease that does not respond to the two main drugs used to treat TB. The two-year regimen for treating DR-TB is extremely arduous and can cause patients to become blind or deaf and can cause organ failure. MSF is calling for better diagnosis and treatment for DR-TB. Support the Test Me, Treat Me DR-TB Manifesto. Sign now at http://msfaccess.org/TBmanifesto/.

Pages